The first presentation of COVID-19 two hours after vaccination in a patient with multiple sclerosis:  Can COVID vaccine provoke cytokine storm in a patient with asymptomatic COVID-19?

Fereshteh Ghadiri Multiple Sclerosis Research Center, Neuroscience institute, Tehran University of Medical Sciences, Tehran, Iran
Mohammad Ali Sahraian Multiple Sclerosis Research Center, Neuroscience institute, Tehran University of Medical Sciences, Tehran, Iran
Abdorreza Naser Moghadasi Multiple Sclerosis Research Center, Neuroscience institute, Tehran University of Medical Sciences, Tehran, Iran

DOI: https://doi.org/10.18502/cjn.v20i4.8353

Keywords: COVID-19; Vaccination; Multiple Sclerosis; Virology; Rituximab

The article's abstract is not available.

Published

2022-01-12

Issue

Section

Articles